FrancophonIA/ELRC3.0 huggingface dataset:
English: G3/4 AST increased (< 3%); G3/4 ALT increased (< 2%)
Slovenian: S3/4 zvišanje AST (< 1 S3/4 zvišanje ALT (< 1
English: Thrombocytopenia (G3/4: Febrile neutropenia
Slovenian: trombocitopenija, (S3/4: 0,6 %), febrilna nevtropenija
English: Hot flush (G3/4: 0.5%) Hypotension (G3/4: Phlebitis (G3/4: 0%)
Slovenian: hipotenzija (S3/4: 0 %) vnetje žile (S 3/4: 0 %)
English: Description of selected adverse reactions in breast cancer for docetaxel 100 mg/m2 single agent
Slovenian: Opis izbranih neželenih učinkov monoterapije z zdravilom docetaksel 100 mg/m2 pri raku dojke
English: Hypersensitivity (G3/4: 1.7%)
Slovenian: Srčne bolezni miokardna ishemija (S3/4: 1,7 %)
English: Anaemia (G3/4: 6.9%); Thrombocytopenia (G4: 0.5%)
Slovenian: 51,5 %), anemija (S3/4: trombocitopenija (S4: 0,5 %)
English: Intravenous use
Slovenian: uporaba
English: What Docetaxel Accord looks like and contents of the pack Docetaxel Accord concentrate for solution for infusion is a clear pale yellow to brownish-yellow solution.
Slovenian: Docetaksel Accord koncentrat za raztopino za infundiranje je prozorna bledorumena do rjavorumena raztopina.
English: Tabulated list of adverse reactions in breast cancer for docetaxel 100 mg/m2 single agent
Slovenian: Tabelarični prikaz neželenih učinkov monoterapije z zdravilom docetaksel 100 mg/m2 pri raku dojke
English: Number of patients
Slovenian: Posebne skupine bolnikov:
English: Neutropenia (G3/4: 76.3%); Anaemia (G3/4: 9.2%);
Slovenian: Bolezni krvi in limfatičnega sistema nevtropenija (S3/4: 76,3 anemija (S3/4: 9,2 %), trombocitopenija (S3/4:
English: Epistaxis (G3/4: < 1%)
Slovenian: dermatitis, eritematozen izpuščaj (S3/4: < 1 %),
English: Uncommon adverse reactions connective tissue disorders General disorders and administration site conditions
Slovenian: Presnovne in prehranske motnje anoreksija Psihiatrične motnje nespečnost
English: Tabulated list of adverse reactions in non-small cell lung cancer for docetaxel 75 mg/m2 in combination with cisplatin
Slovenian: Tabelarični prikaz neželenih učinkov zdravljenja z zdravilom docetaksel 75 mg/m2 pri nedrobnoceličnem pljučnem raku v kombinaciji s cisplatinom Organski sistemi po
English: LIST OF EXCIPIENTS
Slovenian: DRUGI PODATKI CITOTOKSIČNO
English: Uncommon adverse reactions disorders
Slovenian: Organski sistemi po MedDRA Zelo pogosti neželeni učinki
English: Myalgia (severe: 1.4%)
Slovenian: 1,4 %), astenija (8,5 % v prim.
English: Pyrexia (G3/4: NA); Oedema peripheral (G3/4: 0.2%)
Slovenian: Splošne težave in spremembe na mestu aplikacije astenija (S3/4: 10.0 %), vročica (S3/4: NA), periferni edemi (S3/4: 0,2 %)
English: Stomatitis/Pharyngitis (G3/4: Vomiting (G3/4: 1.2%)
Slovenian: bolečine v prebavilih (S3/4: 1,2 %), gastrointestinalna krvavitev (S3/4: 0,4 %)
English: Parameter
Slovenian: Odmerjanje:
English: Tabulated list of adverse reactions in non-small cell lung cancer for docetaxel 75 mg/m2 single agent
Slovenian: Tabelarični prikaz neželenih učinkov monoterapije z zdravilom docetaksel 75 mg/m2 pri nedrobnoceličnem pljučnem raku
English: Asthenia (severe: 12.4%); Fluid retention (severe: 0.8%); Pain
Slovenian: Splošne težave in spremembe na mestu aplikacije astenija (huda: 12,4 %), zastajanje tekočine (hudo: bolečine
English: Ethanol anhydrous Citric acid anhydrous
Slovenian: 6.1 Seznam pomožnih snovi polisorbat 80 brezvodni etanol brezvodna citronska kislina
English: Docetaxel Accord 20 mg/1 ml contains
Slovenian: Zdravilo Docetaksel Accord vsebuje etanol (alkohol) Docetaksel Accord 20 mg/1 ml vsebuje
English: Date of first authorisation:12 June 2009
Slovenian: Datum prve odobritve: 12. junij 2009
English: This leaflet was last revised in {MM/YYYY}
Slovenian: Navodilo je bilo nazadnje revidirano {MM/LLLL}.
English: The absolute bioavailability from the tablet was found to be about 77 %.
Slovenian: Absolutna biološka uporabnost tablete znaša približno 77 %.
English: The marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Slovenian: • Redno posodobljena poročila o varnosti zdravila (PSUR) Imetnik dovoljenja za promet z zdravilom mora redno posodobljena poročila o varnosti zdravila za to zdravilo predložiti v skladu z zahtevami, določenimi v seznamu referenčnih datumov Unije (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES in objavljenem na evropskem spletnem
English: Distribution Volume of distribution is about 0.15 l/kg and serum protein binding is about 98%.
Slovenian: Volumen porazdelitve znaša približno 0,15 l/kg, vezava na serumske beljakovine pa približno 98 %.
English: GORD diagnosis in these studies was based on endoscopic assessment, with the exception of one study in which the inclusion of the patients was based on symptomatology alone.
Slovenian: V teh študijah je diagnoza GERB temeljila na endoskopski oceni, z izjemo ene študije, v katero so bili bolniki vključeni le na
English: You must not use PANTECTA Control if you are taking atazanavir.
Slovenian: Control ne smete uporabljati, če jemljete atazanavir.
English: The expiry date refers to the last day of that month.
Slovenian: Rok uporabnosti zdravila se izteče zadnji dan navedenega
English: If affected, patients should not drive or use machines.
Slovenian: V tem primeru bolniki ne smejo voziti vozil ali upravljati s stroji.
English: Hypromellose Povidone K25
Slovenian: Obloga hipromeloza povidon K25
English: • They are aged over 55 years with new or recently changed symptoms.
Slovenian: • če so starejši od 55 let in so se jim pojavili novi simptomi ali pa so se ti pred kratkim
English: It has been shown that co-administration of atazanavir 300 mg/ritonavir 100 mg with omeprazole (40 mg once daily) or atazanavir 400 mg with lansoprazole (60 mg single dose) to healthy volunteers resulted in a substantial reduction in the bioavailability of atazanavir.
Slovenian: Dokazano je bilo, da se pri sočasni uporabi atazanavirja 300 mg/ritonavirja 100 mg z omeprazolom (40 mg enkrat na dan) ali atazanavirja 400 mg z lansoprazolom (60 mg v enkratnem odmerku) pri zdravih prostovoljcih znatno zmanjša biološka uporabnost atazanavirja.
English: Doses up to 240 mg administered intravenously over 2 minutes were well tolerated.
Slovenian: Odmerke do 240 mg intravensko, aplicirane v 2 minutah, so preiskovanci dobro prenašali.
English: Approximately 5% of patients can be expected to experience adverse reactions .
Slovenian: Neželeni učinki se lahko pojavijo pri 5 % bolnikov.
English: It is unknown whether pantoprazole is excreted in human breast milk.
Slovenian: Ni znano, če se pri človeku pantoprazol izloča v materino mleko.
English: What PANTECTA Control is and what it is used for
Slovenian: Kaj je zdravilo PANTECTA Control in za kaj ga uporabljamo
English: Driving and using machines If you experience side effects like dizziness or disturbed vision, you should not drive or use machines.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Če se pojavijo neželeni učinki, kot so omotica ali motnje vida, ne smete voziti vozil ali upravljati s stroji.
English: Especially, patients over 55 years taking any non-prescription indigestion or heartburn remedy on a daily basis should inform their pharmacist or doctor.
Slovenian: Bolniki, predvsem starejši od 55 let, ki zaradi dispeptičnih težav ali zgage vsakodnevno jemljejo katero koli zdravilo brez recepta, morajo o tem obvestiti svojega farmacevta ali
English: What you need to know before you take PANTECTA Control
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo PANTECTA Control
English: ‘Other medicines and PANTECTA Control'.
Slovenian: “Druga zdravila in zdravilo PANTECTA Control” v nadaljevanju.
English: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Slovenian: Pri uporabi pantoprazola so poročali o naslednjih neželenih učinkih, ki so v tabeli v nadaljevanju navedeni v skladu z navedbo pogostnosti po MedDRA: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana (ni mogoče oceniti iz razpoložljivih podatkov).
English: Animal studies have shown excretion of pantoprazole in breast milk.
Slovenian: Študije na živalih so pokazale, da se pantoprazol izloča v mleko samic.
English: The mechanism leading to the formation of gastric carcinoids by substituted benzimidazoles has been carefully investigated and allows the conclusion that it is a secondary reaction to the massively elevated serum gastrin levels occurring in the rat during chronic high-dose treatment.
Slovenian: Mehanizem nastanka želodčnih karcinoidov s substituiranimi benzimidazoli so natančno preučili in zaključili, da gre za sekundarno reakcijo na močno zvišano raven gastrina v serumu, ki se pojavi pri podganah med kroničnim
English: PANTECTA Control may reduce the absorption of active substances whose bioavailability is dependent on the gastric pH (e.g. ketoconazole).
Slovenian: Zdravilo PANTECTA Control lahko zmanjša absorpcijo zdravilnih učinkovin, katerih biološka uporabnost je odvisna od pH želodčnega soka (npr. ketokonazol).
English: - if you are taking a medicine containing atazanavir (for the treatment of HIV-infection) See
Slovenian: - če jemljete zdravilo, ki vsebuje atazanavir (za zdravljenje okužbe z virusom HIV).
English: Do not take PANTECTA Control: - if you are allergic to pantoprazole or to any of the other ingredients of this medicine (listed in section 6).
Slovenian: - če ste alergični na pantoprazol ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Co-administration with atazanavir (see section 4.5).
Slovenian: Sočasno zdravljenje skupaj z atazanavirjem (glejte poglavje 4.5).
English: - You should not take PANTECTA Control tablets for more than 4 weeks without consulting a doctor.
Slovenian: - PANTECTA Control tablet ne smete jemati dlje kot 4 tedne brez posveta z zdravnikom.
English: Biotransformation Pantoprazole is almost exclusively metabolized in the liver.
Slovenian: Pantoprazol se skoraj izključno presnavlja v jetrih.
English: België/Belgique/Belgien Takeda Belgium Tél/Tel: + 32 2 464 06 11 takeda-belgium@takeda.com
Slovenian: Luxembourg/Luxemburg Takeda Belgium Tél/Tel: + 32 2 464 06 11 takeda-belgium@takeda.com
English: However, you may take PANTECTA Control with antacids (e.g. magaldrate, alginic acid, sodium bicarbonate, aluminium hydroxide, magnesium carbonate, or combinations thereof), if needed.
Slovenian: Zdravilo PANTECTA Control lahko po potrebi jemljete skupaj z antacidi (npr. magaldrat, alginska kislina, natrijev hidrogenkarbonat, aluminijev hidroksid, magnezijev karbonat ali kombinacije naštetih).
English: Stevens-Johnson syndrome; Lyell syndrome;
Slovenian: StevensJohnsonov sindrom, Lyellov sindrom, multiformni eritem, fotosenzitivnost
English: Due to the specific binding of pantoprazole to the proton pumps within the parietal cell, the elimination half-life does not correlate with the much longer duration of action (inhibition of acid secretion).
Slovenian: Zaradi specifične vezave pantoprazola na protonsko črpalko znotraj parietalnih celic, razpolovni čas izločanja ni v korelaciji z njegovim veliko daljšim časom trajanja delovanja
English: PANTECTA Control contains the active substance pantoprazole, which blocks the ‘pump' that produces stomach acid.
Slovenian: Zdravilo PANTECTA Control vsebuje zdravilno učinkovino pantoprazol, ki zavira “črpalko”, ki proizvaja želodčno kislino.
English: Do not take PANTECTA Control with other medicines which limit the amount of acid produced in your stomach, such as another proton pump inhibitor (omeprazole, lansoprazole or rabeprazole) or an H2 antagonist (e.g. ranitidine, famotidine).
Slovenian: Ne jemljite zdravila PANTECTA Control z drugimi zdravili, ki zavirajo izločanje želodčne kisline, kot so drugi zaviralci protonske črpalke (omeprazol, lansoprazol ali rabeprazol) ali antagonisti histaminskih receptorjev H2 (npr. ranitidin, famotidin).
English: You should swallow the tablet whole with some water.
Slovenian: Tableto morate pogoltniti celo skupaj z nekaj
English: Pantoprazole should not be used during breast-feeding.
Slovenian: Pantoprazola ne smete uporabljati med dojenjem.
English: If no symptom relief is obtained within 2 weeks of continuous treatment, the patient should be instructed to consult a doctor.
Slovenian: Če se simptomi po 2 tednih neprekinjenega zdravljenja ne izboljšajo, se mora bolnik posvetovati s
English: Medicinal product not subject to medical prescription.
Slovenian: Izdaja zdravila je brez recepta v lekarnah.
English: In the 2-year rodent studies an increased number of liver tumors was observed in rats (in one rat study only) and in female mice and was interpreted as being due to pantoprazole's high metabolic rate in the liver.
Slovenian: V 2-letnih študijah pri glodavcih so pri podganah (samo v 1 študiji) in pri mišjih samicah opazili povečano število jetrnih tumorjev, kar naj bi bila posledica močno povečanega presnavljanja
English: Coating: hypromellose, povidone, titanium dioxide (E171), yellow iron oxide (E172), propylene glycol, methacrylic acid-ethyl acrylate copolymer, sodium lauril sulfate, polysorbate 80, triethyl citrate.
Slovenian: - Obloga: hipromeloza, povidon, titanov dioksid (E171), rumeni železov oksid (E172), propilenglikol, kopolimer metakrilne kisline in etilakrilata, natrijev lavrilsulfat, polisorbat 80 in trietilcitrat.
English: Patients should not take another proton pump inhibitor or H2 antagonist concomitantly.
Slovenian: Bolniki sočasno ne smejo jemati drugega zaviralca protonske črpalke ali antagonista histaminskih
English: What PANTECTA Control contains - The active substance is pantoprazole.
Slovenian: Kaj vsebuje zdravilo PANTECTA Control - Zdravilna učinkovina je pantoprazol.
English: This medicine may not bring immediate relief.
Slovenian: To zdravilo vam morda ne bo prineslo
English: PANTECTA Control is not recommended for use in children and adolescents below 18 years of age due to insufficient data on safety and efficacy.
Slovenian: Zaradi nezadostnih podatkov o varnosti in učinkovitosti uporaba zdravila PANTECTA Control pri otrocih in mladostnikih, mlajših od 18 let, ni priporočljiva.
English: What PANTECTA Control is and what it is used for What you need to know before you take PANTECTA Control How to take PANTECTA Control Possible side effects
Slovenian: Kaj je zdravilo PANTECTA Control in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo PANTECTA Control
English: You may experience relief from your acid reflux and heartburn symptoms after just one day of treatment with PANTECTA Control, but this medicine is not meant to bring immediate relief.
Slovenian: Simptomi kislega refluksa in zgage se lahko ublažijo že po enem dnevu zdravljenja z zdravilom PANTECTA Control, vendar pa to zdravilo ni namenjeno za dosego takojšnjega olajšanja.
English: In animal studies (rats) 5 mg/kg was the observed NOAEL (No Observed Adverse Effect Level) for embryotoxicity.
Slovenian: Koncentracija, pri kateri ni mogoče opaziti neželenih učinkov (NOAEL; “No Observed Adverse Effect Level”), je v študijah pri živalih (podgane) za embriotoksičnost znašala 5 mg/kg.
English: - Frequency not known: hallucination, confusion (especially in patients with a history of these symptoms); decreased level of sodium in blood; decreased level of magnesium in blood.
Slovenian: - Pogostnost neznana (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti): halucinacije, zmedenost (še posebej pri bolnikih, ki so te bolezenske znake že imeli), zmanjšanje vrednosti natrija v krvi, zmanjšanje vrednosti magnezija v krvi.
English: If you have been suffering from repetitive heartburn or indigestion symptoms for some time, remember to see your doctor regularly.
Slovenian: Če ponavljajoča se zgaga in dispeptične težave trajajo že nekaj časa, morate redno obiskovati svojega
English: Printing ink
Slovenian: Tiskarsko črnilo šelak
English: If you take more PANTECTA Control than you should Tell your doctor or pharmacist if you have taken more than the recommended dose.
Slovenian: Če ste vzeli večji odmerek zdravila PANTECTA Control, kot bi smeli Če ste vzeli večji odmerek zdravila PANTECTA Control, kot bi smeli, o tem obvestite svojega zdravnika ali farmacevta.
English: Posology The recommended dose is 20 mg pantoprazole (one tablet) per day.
Slovenian: Priporočeni odmerek je 20 mg pantoprazola (ena tableta) na dan.
English: Special populations No dose adjustment is necessary in elderly patients or in those with impaired renal or liver function.
Slovenian: Pri starejših bolnikih in bolnikih z okvaro delovanja ledvic ali jeter odmerka ni treba prilagajati.
English: Core: sodium carbonate (anhydrous), mannitol, crospovidone, povidone K90, calcium stearate.
Slovenian: - Pomožne snovi so: - Jedro: brezvodni natrijev karbonat, manitol, krospovidon, povidon K90 in kalcijev stearat.
English: PANTECTA Control 20 mg gastro-resistant tablets
Slovenian: PANTECTA Control 20 mg gastrorezistentne tablete
English: Printing ink: shellac, red, black and yellow iron oxide (E172) and ammonia solution, concentrated.
Slovenian: - Tiskarsko črnilo: šelak, rdeči, črni in rumeni železov oksid (E 172) ter koncentrirana
English: Takeda France S.A.S.
Slovenian: Takeda Italia S.p.A.
English: PANTECTA Control 20 mg gastro-resistant tablets Pantoprazole
Slovenian: PANTECTA Control 20 mg gastrorezistentne tablete pantoprazol
English: There was no evidence of impaired fertility following the administration of pantoprazole in animal studies (see section 5.3).
Slovenian: Pri študijah na živalih uporaba pantoprazola ni vplivala na plodnost (glejte poglavje 5.3).
English: Do not take a double dose to make up for the forgotten dose.
Slovenian: Če ste pozabili vzeti zdravilo PANTECTA Control Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmerek.
English: You may need further blood tests - methotrexate (used to treat rheumatoid arthritis, psoriasis, and cancer) - if you are taking methotrexate your doctor may temporarily stop your PANTECTA Control treatment because pantoprazole can increase levels of methotrexate in the blood.
Slovenian: Če jemljete metotreksat, lahko zdravnik začasno prekine zdravljenje z zdravilom PANTECTA Control, saj lahko pantoprazol zviša vrednosti metotreksata v krvi.
English: Especially medicines containing one of the following active substances: - atazanavir (used to treat HIV-infection).
Slovenian: Zdravilo PANTECTA Control lahko vpliva na delovanje nekaterih drugih zdravil, še posebej zdravil, ki vsebujejo naslednje zdravilne učinkovine: - atazanavir (uporabljamo ga za zdravljenje okužbe z virusom HIV).
English: Therefore, pantoprazole must not be co-administered with atazanavir (see section 4.3).
Slovenian: Absorpcija atazanavirja je odvisna od pH. Zaradi tega se pantoprazola ne sme uporabljati sočasno z atazanavirjem (glejte poglavje 4.3).
English: Musculoskeletal and connective tissue disorders
Slovenian: Bolezni mišičnoskeletnega sistema in vezivnega tkiva artralgija, mialgija
English: - Uncommon side effects(may affect up to 1 in 100 people): headache; dizziness; diarrhoea; feeling sick, vomiting; bloating and flatulence (wind); constipation; dry mouth; bellyache and discomfort; skin rash or hives; itching; feeling weak, exhausted or generally unwell; sleep disorders; increase in liver enzymes in a blood test.
Slovenian: - Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov): glavobol, omotica, driska, siljenje na bruhanje, bruhanje, napihnjenost in vetrovi, zaprtost, suha usta, bolečina in neugodje v predelu trebuha, kožni izpuščaj ali koprivnica, srbenje, oslabelost, izčrpanost ali splošno slabo počutje, motnje spanja, zvišane vrednosti jetrnih encimov pri krvni
English: What PANTECTA Control looks like and contents of the pack The gastro-resistant tablets are yellow, oval, biconvex film-coated tablets imprinted with “P20” on one side.
Slovenian: Izgled zdravila PANTECTA Control in vsebina pakiranja Gastrorezistentne tablete so rumene, ovalne, obojestransko izbočene filmsko obložene tablete z Zdravilo PANTECTA Control je na voljo v Alu/Alu pretisnih omotih s kartonsko oporo ali brez nje.
English: Tablets should be swallowed whole.
Slovenian: Tablete je treba pogoltniti cele skupaj s tekočino pred obrokom.
English: PANTECTA Control is used for the short-term treatment of reflux symptoms (for example heartburn, acid regurgitation) in adults.
Slovenian: Zdravilo PANTECTA Control uporabljamo za kratkotrajno zdravljenje simptomov refluksa (na primer zgaga, regurgitacija kisline) pri odraslih.
English: Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines PANTECTA Control may stop certain other medicines from working properly.
Slovenian: Druga zdravila in zdravilo PANTECTA Control Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
English: - If you get any side effects , talk to your doctor or pharmacist.
Slovenian: - Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom ali s farmacevtom.
English: PANTECTA Control 20 mg gastro-resistant tablets should not be chewed or crushed, and should be swallowed whole with liquid before a meal.
Slovenian: PANTECTA Control 20 mg gastrorezistentnih tablet se ne sme žvečiti ali drobiti.
English: PANTECTA Control should not be used by children and adolescents under 18 years of age due to a lack of safety information in this younger age group..
Slovenian: Zdravila PANTECTA Control ne smejo jemati otroci in mladostniki, mlajši od 18 let.
English: PANTECTA Control is indicated for short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
Slovenian: Zdravilo PANTECTA Control je indicirano za kratkotrajno zdravljenje simptomov refluksa (npr. zgaga, regurgitacija kisline) pri odraslih.
English: spearmint, fatty and fried food, acidic food, spicy food, citrus fruits and fruit juices, tomatoes.
Slovenian: poprova meta, zelena meta, mastne in ocvrte jedi, kisla hrana, začinjena hrana, agrumi, sadni
English: Takeda GmbH
Slovenian: Takeda Pharma Ges.m.b.H.
English: Titanium dioxide (E171) Yellow iron oxide (E172) Propylene glycol
Slovenian: titanov dioksid (E171) rumeni železov oksid (E172) propilenglikol kopolimer metakrilne kisline in etilakrilata (1:1) natrijev lavrilsulfat polisorbat 80 trietilcitrat
English: Patients should not take pantoprazole as a preventive medicinal product.
Slovenian: Bolniki pantoprazola ne smejo
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila
English: Other medicines and PANTECTA Control
Slovenian: Zdravila PANTECTA
English: PANTECTA Control has no or negligible influence on the ability to drive and use machines.
Slovenian: Zdravilo PANTECTA Control nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji, vendar pa se lahko pojavijo neželeni učinki, kot so omotica in motnje vida (glejte poglavje 4.8).
English: Pantoprazole is converted to its active form, a cyclic sulphenamide, in the acidic environment in the parietal cells where it inhibits the H+, K+-ATPase enzyme, i. e. the final stage in the production of hydrochloric acid in the stomach.
Slovenian: Pantoprazol se v svojo aktivno obliko, ciklični sulfenamid, pretvori v kislem okolju parietalnih celic,
English: Sodium carbonate, anhydrous Mannitol (E421) Crospovidone
Slovenian: manitol (E421) krospovidon povidon K90 kalcijev stearat
English: Do not chew or break the tablet.
Slovenian: - Izogibajte se tesno oprijetim oblačilom ali nošenju pasov.
English: Elderly
Slovenian: Norge
English: Pharmacotherapeutic group: : Drugs for acid related disorders,Proton pump inhibitors, ATC code: A02BC02
Slovenian: Farmakoterapevtska skupina: zdravila za kislinsko pogojene bolezni, zaviralci protonske črpalke,